Scandinavian Mirena Insertion Nulliparous Trial.

NCT00798980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 224

Last updated 2015-04-22

No results posted yet for this study

Summary

In this non-interventional study we investigate the nulliparous women individual evaluation of the insertion procedure of LNG-IUD and the follow-up period of 3 months post insertion.

Conditions

  • Nulliparous

Interventions

DRUG

Mirena (BAY86-5028)

Nulliparous Women

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
14 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-06-30
Completion
2009-11-30

Countries

  • Sweden

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00798980 on ClinicalTrials.gov